# Folic Acid Supplementation in Calcific Aortic Valve Disease

Study · id `cardio:ct-nct05861648` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05861648](<https://clinicaltrials.gov/study/NCT05861648>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05861648

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT05861648. Randomized; double masking; primary purpose prevention. Start 2023-07-01 (anticipated); primary completion 2025-07-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT05861648, source copy `cardio:ctgov-nct05861648-2023-05-17`, retrieved 2026-10-26)
- Planned start: 2023-07-01 (anticipated) (ClinicalTrials.gov record NCT05861648, source copy `cardio:ctgov-nct05861648-2023-05-17`, retrieved 2026-10-26)
- Primary completion: 2025-07-01 (anticipated) (ClinicalTrials.gov record NCT05861648, source copy `cardio:ctgov-nct05861648-2023-05-17`, retrieved 2026-10-26)
- Completion: 2028-07-01 (anticipated) (ClinicalTrials.gov record NCT05861648, source copy `cardio:ctgov-nct05861648-2023-05-17`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05861648-2023-05-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Folic Acid Supplementation in Calcific Aortic Valve Disease
- Condition: Calcification of Aortic Valve
- Condition: Aortic Valve Stenosis
- Intervention (Drug): Folic Acid Oral Tablet
- Intervention (Dietary supplement): Placebo
- Lead sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (`cardio:org-union-hospital-tongji-medical-college-huazhong-university-090806`)

## Provenance

Content hash: e745414fed2823e1fd97a258a3f1aced8532cc8a34f019dcdd50592796fa1f1a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
